Impaired Nitric Oxide–Mediated Renal Vasodilation in Rats With Experimental Heart Failure

Circulation ◽  
1997 ◽  
Vol 96 (10) ◽  
pp. 3655-3664 ◽  
Author(s):  
Zaid A. Abassi ◽  
Konstantin Gurbanov ◽  
Susan E. Mulroney ◽  
Clariss Potlog ◽  
Terry J. Opgenorth ◽  
...  
1994 ◽  
Vol 23 (6) ◽  
pp. 976 ◽  
Author(s):  
Georg Noll ◽  
Marcel R. Tschudi ◽  
Dragutin Novosel ◽  
Thomas F. Lüscher

JCI Insight ◽  
2018 ◽  
Vol 3 (4) ◽  
Author(s):  
Nicola Wilck ◽  
Lajos Markó ◽  
András Balogh ◽  
Kristin Kräker ◽  
Florian Herse ◽  
...  

2000 ◽  
Vol 99 (s43) ◽  
pp. 7P-7P
Author(s):  
DA MacDougall ◽  
S Currie ◽  
A McPhaden ◽  
SM Cobbe ◽  
AJB Brady

Author(s):  
Chi-Ming Wei ◽  
Margarita Bracamonte ◽  
Shi-Wen Jiang ◽  
Richard C. Daly ◽  
Christopher G.A. McGregor ◽  
...  

Nitric oxide (NO) is a potent endothelium-derived relaxing factor which also may modulate cardiomyocyte inotropism and growth via increasing cGMP. While endothelial nitric oxide synthase (eNOS) isoforms have been detected in non-human mammalian tissues, expression and localization of eNOS in the normal and failing human myocardium are poorly defined. Therefore, the present study was designed to investigate eNOS in human cardiac tissues in the presence and absence of congestive heart failure (CHF).Normal and failing atrial tissue were obtained from six cardiac donors and six end-stage heart failure patients undergoing primary cardiac transplantation. ENOS protein expression and localization was investigated utilizing Western blot analysis and immunohistochemical staining with the polyclonal rabbit antibody to eNOS (Transduction Laboratories, Lexington, Kentucky).


Sign in / Sign up

Export Citation Format

Share Document